Advanced Ovarian Cancer: A Personal Story of Resilience and Hope
Diane Davis’s journey with advanced ovarian cancer is a testament to the importance of molecular genetic testing and the impact of Lynch syndrome on families. After months of debilitating symptoms, including lower back pain and nausea, Davis was diagnosed with a softball-sized ovarian tumor that had spread to other organs.
Her diagnosis was met with a mix of emotions – devastation, relief, and a sense of finally having an answer. Dr. Christopher Darus, a gynecologic oncologist at MaineHealth Maine Medical Center, outlined a treatment plan that included chemotherapy. However, after three cycles, a new mass was found in her pelvis, indicating an extremely rare and ominous recurrence of the cancer.
Lynch Syndrome: A Genetic Connection
Molecular testing revealed that Davis had Lynch syndrome, a condition that increases the risk of various forms of cancer, including ovarian cancer. Dr. Paul Oberstein, a medical oncologist at NYU Langone, explains that Lynch syndrome is “essentially a cancer syndrome” caused by mutations in proteins that help repair DNA.
With this new information, Davis’s treatment options expanded to include immunotherapy. Checkpoint inhibitors, such as pembrolizumab, were used to “unmask” her tumors and allow her immune system to attack the cancer cells. The results were remarkable, with the new mass in her pelvis disappearing within two treatments.
A New Lease on Life
Davis’s diagnosis with Lynch syndrome also had a significant impact on her family. Her brother, sisters, and daughter were all tested, and her daughter was found to have the condition. Early cancer screenings led to the removal of a precancerous polyp, potentially saving her life.
Today, Davis is in complete remission, thanks to immunotherapy treatment. She remains vigilant, getting regular scans and monitoring her health. Her story highlights the importance of molecular genetic testing and the need for awareness about Lynch syndrome.
For more information on advanced ovarian cancer, molecular genetic testing, and Lynch syndrome, visit Here
Image Source: www.cbsnews.com
